Concepedia
4
Publications
311
Citations
H-Index
2015
Active since
Affiliations
Regeneron (United States)(Current)
Evan Herlihy is an author at Regeneron (United States) specializing in drug discovery, radiation oncology, and medicine.
Top concepts
MedicinePharmacologyDrug DiscoveryRadiation OncologyBiomolecular Engineering
Publications per year
2015–2022
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies
Dimitris Skokos, Janelle Waite, Lauric Haber et al. · Science Translational Medicine · 2020 · 141 citations
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy
Janelle Waite, Bei Wang, Lauric Haber et al. · Science Translational Medicine · 2020 · 88 citations
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
Joyce Wei, Welby Montalvo-Ortiz, Lola Yu et al. · Science Translational Medicine · 2022 · 49 citations
Design, synthesis and biological evaluation of a highly-potent and cancer cell selective folate–taxoid conjugate
Joshua D. Seitz, Jacob G. Vineberg, Evan Herlihy et al. · Bioorganic & Medicinal Chemistry · 2015 · 33 citations · Full text
Medicine, Drug Discovery, Bioconjugation +5
Rows per page
1–4 of 4